Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes

Neuropeptides

Volumn 38, Issue 4, 2004, Pages 153-161

  Koglin, Norman ^a   Beck Sickinger, Annette G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

NPY; Radiolabelling; Selective analogues; Tumor diagnosis; Tumor therapy

Indexed keywords

IODINE 125; NEUROPEPTIDE; NEUROPEPTIDE Y [11-18 DEALANYLALANINE][7,21 CYSTEINE 9 DEXTRO ACETYLLYSINE 26 DEXTRO HISTIDINE 34 PROLINE]; NEUROPEPTIDE Y [31 ALANINE 32 AMINOISOBUTYRIC ACID]; NEUROPEPTIDE Y [31 ALANINE 32 PROLINE]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE] I 125; NEUROPEPTIDE Y [32 DEXTRO TRYPTOPHAN]; NEUROPEPTIDE Y [34 DEXTRO TRYPTOPHAN]; NEUROPEPTIDE Y [7 PHENYLALANINE 34 PROLINE]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y I 125; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY; RADIOLIGAND; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ACYLATION; ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CANCER DIAGNOSIS; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CHIMERA; CONFORMATIONAL TRANSITION; COVALENT BOND; CYCLIZATION; DRUG SYNTHESIS; FOOD INTAKE; ISOTOPE LABELING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RADIOACTIVITY; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION; TUMOR DIAGNOSIS;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NEUROPEPTIDE Y; PROTEIN ISOFORMS; RADIOISOTOPES; RECEPTORS, NEUROPEPTIDE Y;

EID: 4344583193     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2004.04.002     Document Type: Review

References (40)

1. Bader R., Bettio A., Beck-Sickinger A.G., Zerbe O. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. J. Mol. Biol. 305:2001;307-329
2. Bader R., Rytz G., Lerch M., Beck-Sickinger A.G., Zerbe O. Key motif to gain selectivity at the neuropeptide Y5-receptor: structure and dynamics of micelle-bound [Ala31, Pro32]-NPY. Biochemistry. 41:2002;8031-8042
3. Beck-Sickinger A.G., Jung G. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Biopolymers. 37:1995;123-142
4. Beck-Sickinger A.G., Jung G., Gaida W., Koppen H., Schnorrenberg G., Lang R. Structure/activity relationships of C-terminal neuropeptide Y peptide segments and analogues composed of sequence 1-4 linked to 25-36. Eur. J. Biochem. 194:1990;449-456
5. Bettio A., Beck-Sickinger A.G. Biophysical methods to study ligand-receptor interactions of neuropeptide Y. Biopolymers. 60:2001;420-437
6. Bolton A.E., Hunter W.M. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem. J. 133:1973;529-539
7. Cabrele C., Langer M., Bader R., Wieland H.A., Doods H.N., Zerbe O., Beck-Sickinger A.G. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J. Biol. Chem. 275:2000;36043-36048
8. Cabrele C., Wieland H.A., Langer M., Stidsen C.E., Beck-Sickinger A.G. Y-receptor affinity modulation by the design of pancreatic polypeptide/ neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity. Peptides. 22:2001;365-378
9. Cabrele C., Wieland H.A., Koglin N., Stidsen C., Beck-Sickinger A.G. Ala31-Aib32: identification of the key motif for high affinity and selectivity of neuropeptide Y at the Y5-receptor. Biochemistry. 41:2002;8043-8049
10. Chang R.S., Lotti V.J., Chen T.B., Cerino D.J., Kling P.J. Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens. Life Sci. 37:1985;2111-2122
11. Chang R.S., Lotti V.J., Chen T.B. Specific [3H]propionyl-neuropeptide Y (NPY) binding in rabbit aortic membranes: comparisons with binding in rat brain and biological responses in rat vas deferens. Biochem. Biophys. Res. Commun. 151:1988;1213-1219
12. Dumont Y., Martel J.C., Fournier A., St-Pierre S., Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol. 38:1992;125-167
13. Dumont Y., Thakur M., Beck-Sickinger A., Fournier A., Quirion R. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY. Br. J. Pharmacol. 139:2003;1360-1368
14. 99mTc-aquaion labels peptide to an unprecedented high specific activity. J. Nucl. Med. 40:1999;1913-1917
15. Fabry M., Langer M., Rothen-Rutishauser B., Wunderli-Allenspach H., Hocker H., Beck-Sickinger A.G. Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur. J. Biochem. 267:2000;5631-5637
16. Fuhlendorff J., Gether U., Aakerlund L., Langeland-Johansen N., Thogersen H., Melberg S.G., Olsen U.B., Thastrup O., Schwartz T.W. [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc. Natl. Acad. Sci. USA. 87:1990;182-186
17. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171
18. Gray T.S., Morley J.E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci. 38:1986;389-401
19. Heppeler A., Froidevaux S., Eberle A.N., Maecke H.R. Receptor targeting for tumor localisation and therapy with radiopeptides. Curr. Med. Chem. 7:2000;971-994
20. Kirby D.A., Boublik J.H., Rivier J.E. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions. J. Med. Chem. 36:1993;3802-3808
21. Koglin N., Lang M., Rennert R., Beck-Sickinger A.G. Facile and selective nanoscale labeling of peptides in solution by using photolabile protecting groups. J. Med. Chem. 46:2003;4369-4372
22. Koglin N., Zorn C., Beumer R., Cabrele C., Bubert C., Sewald N., Reiser O., Beck-Sickinger A.G. Analogues of neuropeptide Y containing beta-aminocyclopropane carboxylic acids are the shortest linear peptides that are selective for the Y1 receptor. Angew. Chem. Int. Ed. Engl. 42:2003;202-205
23. Korner M., Waser B., Reubi J.C. Neuropeptide Y receptor expression in human primary ovarian neoplasms. Lab. Invest. 84:2004;71-80
24. Langer M., Beck-Sickinger A.G. Peptides as carrier for tumor diagnosis and treatment. Curr. Med. Chem. Anti-Canc. Agents. 1:2001;71-93
25. 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. Bioconjug. Chem. 12:2001;1028-1034
26. Larhammar D. Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept. 62:1996;1-11
27. Mullins D., Kirby D., Hwa J., Guzzi M., Rivier J., Parker E. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo. Mol. Pharmacol. 60:2001;534-540
28. Parker E.M., Balasubramaniam A., Guzzi M., Mullins D.E., Salisbury B.G., Sheriff S., Witten M.B., Hwa J.J. [D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake. Peptides. 21:2000;393-399
29. Pedrazzini T., Pralong F., Grouzmann E. Neuropeptide Y: the universal soldier. Cell Mol. Life Sci. 60:2003;350-377
30. Reubi J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 24:2003;389-427
31. Reubi J.C., Gugger M., Waser B., Schaer J.C. Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res. 61:2001;4636-4641
32. Reubi C., Gugger M., Waser B. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting. Eur. J. Nucl. Med. Mol. Imaging. 29:2002;855-862
33. Schibli R., La Bella R., Alberto R., Garcia-Garayoa E., Ortner K., Abram U., Schubiger P.A. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjug. Chem. 11:2000;345-351
34. Schmeisser H., Kontsekova E., Vancova I., Mucha V., Kontsek P. Radioiodination of human interferon-. α2 interferes with binding of C-terminal specific antibodies J. Immunol. Methods. 238:2000;81-85
35. Schober D.A., Gackenheimer S.L., Gehlert D.R. Pharmacological characterization of neuropeptide Y-(2-36) binding to neuropeptide Y Y1 and Y2 receptors. Eur. J. Pharmacol. 318:1996;307-313
36. Soll R.M., Dinger M.C., Lundell I., Larhammer D., Beck-Sickinger A.G. Novel analogues of neuropeptide Y with a preference for the Y1-receptor. Eur. J. Biochem. 268:2001;2828-2837
37. Takebayashi Y., Koga H., Togami J., Inui A., Kurihara H., Koshiya K., Furuya T., Tanaka A., Murase K. Design of the Y1-receptor-selective cyclic peptide based on the C-terminal sequence of neuropeptide Y. J. Pept. Res. 56:2000;409-415
38. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660
39. Unden A., Tatemoto K., Mutt V., Bartfai T. Neuropeptide Y receptor in the rat brain. Eur. J. Biochem. 145:1984;525-530
40. Wester H.J., Hamacher K., Stocklin G. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation. Nucl. Med. Biol. 23:1996;365-372